Literature DB >> 111929

Regions of the lipopolysaccharide of Pseudomonas aeruginosa essential for antitumor and interferon-inducing activities.

K Tanamoto, C Abe, J Y Homma, Y Kojima.   

Abstract

Resistance against ascites tumor development and interferon-inducing activity were demonstrated in lipopolysaccharide derived from the protein-lipopolysaccharide complex obtained from an autolysate of Pseudomonas aeruginosa. Lipid A obtained from the lipopolysaccharide was sufficient to induce interferon in vitro but no antitumor activity was found if lipid A or the polysaccharide derived from lipopolysaccharide was injected into the animal. Chemical modification of the polysaccharide portion or deacylation of the lipopolysaccharide also diminished antitumor activity. In contrast, interferon was induced by these incomplete lipopolysaccharides. These results indicate that both the lipid A portion and covalently linked polysaccharide are necessary for the inhibition of ascites tumor development, whereas incomplete lipid A with amide-linked fatty acids is sufficient to induce interferon in vitro.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 111929     DOI: 10.1111/j.1432-1033.1979.tb13152.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Induction of lethal shock and tolerance by Porphyromonas gingivalis lipopolysaccharide in D-galactosamine-sensitized C3H/HeJ mice.

Authors:  K Tanamoto
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

2.  Deacylation of bacterial lipopolysaccharide in rat hepatocytes in vitro.

Authors:  I Fukuda; K Tanamoto; S Kanegasaki; Y Yajima; Y Goto
Journal:  Br J Exp Pathol       Date:  1989-06

3.  Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate.

Authors:  K Tanamoto; U Zähringer; G R McKenzie; C Galanos; E T Rietschel; O Lüderitz; S Kusumoto; T Shiba
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

4.  Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains.

Authors:  R E Hancock; L M Mutharia; L Chan; R P Darveau; D P Speert; G B Pier
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

5.  Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains.

Authors:  R P Darveau; R E Hancock
Journal:  J Bacteriol       Date:  1983-08       Impact factor: 3.490

6.  Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.

Authors:  Erika Vacchelli; Lorenzo Galluzzi; Alexander Eggermont; Wolf Hervé Fridman; Jerome Galon; Catherine Sautès-Fridman; Eric Tartour; Laurence Zitvogel; Guido Kroemer
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110

7.  P. aeruginosa Mediated Necroptosis in Mouse Tumor Cells Induces Long-Lasting Systemic Antitumor Immunity.

Authors:  Jia-Long Qi; Jin-Rong He; Shu-Mei Jin; Xu Yang; Hong-Mei Bai; Cun-Bao Liu; Yan-Bing Ma
Journal:  Front Oncol       Date:  2021-02-12       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.